Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tadasu Kasahara"'
Autor:
Hiroshi Sakura, Naotake Hashimoto, Kazuo Sasamoto, Hiroshi Ohashi, Sumiko Hasumi, Noriko Ujihara, Tadasu Kasahara, Osamu Tomonaga, Hideo Nunome, Masashi Honda, Yasuhiko Iwamoto, for the JAMP Study Investigators
Publikováno v:
BMC Endocrine Disorders, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background To investigate the ameliorating effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood glucose control in patients with type 2 diabetes mellitus who were previously untreated with or who have a poor responsive to exis
Externí odkaz:
https://doaj.org/article/abc9e6be1d1948a0bd3612a4e055e032
Autor:
Yasuhiko Iwamoto, Kazuo Sasamoto, Sumiko Hasumi, Hideo Nunome, Hiroshi Sakura, Noriko Ujihara, Naotake Hashimoto, Masashi Honda, Tadasu Kasahara, Hiroshi Ohashi, Osamu Tomonaga
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus fluctuate throughout the year. However, there are few studies that have evaluated the therapeutic effect of hypoglycemic agents while considering such fluctuati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cee5d8436682c6d27397dae0dcbfc55
https://doi.org/10.1111/jdi.12817
https://doi.org/10.1111/jdi.12817
AIMS: We clarified the clinical background of Japanese patients with type 1 diabetes mellitus (T1DM) who have received insulin therapy for 50 years or longer. METHODS: Of 1,412 patients diagnosed with T1DM at an age younger than 30 years old between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888a0a2140459fe3d5d91a48e758faa6
https://europepmc.org/articles/PMC6763551/
https://europepmc.org/articles/PMC6763551/
Autor:
Chisato Isago, Yasuko Uchigata, Moritoshi Kurita, Yuki Tanaka, Tomoko Nakagami, Tadasu Kasahara, Arata Ito, Yukiko Hasegawa, Junko Oya, Kanako Takahashi
Publikováno v:
Metabolic syndrome and related disorders. 17(5)
Background: Body weight reduction (BWR) of at least 3% in obese Japanese individuals through lifestyle interventions has improved the risk factors for cardiovascular disease (CVD). We aime...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029e2d56682a5dad73ec7ba82e1535cf
https://pubmed.ncbi.nlm.nih.gov/30839239
https://pubmed.ncbi.nlm.nih.gov/30839239
Autor:
Noriko, Ujihara, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Tadasu, Kasahara, Osamu, Tomonaga, Hideo, Nunome, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
Publikováno v:
Diabetology international. 9(1)
[This corrects the article DOI: 10.1007/s13340-017-0330-2.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::92bd4b977ba22f332f68acf15675e9f6
https://pubmed.ncbi.nlm.nih.gov/30603350
https://pubmed.ncbi.nlm.nih.gov/30603350
Autor:
Hideo, Nunome, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Noriko, Ujihara, Tadasu, Kasahara, Osamu, Tomonaga, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
As a subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes (JAMP study), we examined factors that decreased blood glucose control effect of sitagliptin after 3 months and patients requiring an addition or increase of diabetes tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94b48636484fb9a31c7b8f4f016d781
https://europepmc.org/articles/PMC6224911/
https://europepmc.org/articles/PMC6224911/
Autor:
Hiroshi Sakura, Tadasu Kasahara, Naotake Hashimoto, Masashi Honda, Sumiko Hasumi, Yasuhiko Iwamoto, Hideo Nunome, Osamu Tomonaga, Noriko Ujihara, Hiroshi Ohashi, Kazuo Sasamoto
Publikováno v:
Journal of Clinical Medicine Research
Background: The aim of the study was to determine the effects of sitagliptin on renal function in a diabetic population including patients with normal renal function. Methods: We analyzed the association between 12-month, 50 mg/day sitagliptin and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d6b38b47871fa601c53bb9b438f95c
https://pubmed.ncbi.nlm.nih.gov/29238432
https://pubmed.ncbi.nlm.nih.gov/29238432
Autor:
Noriko, Ujihara, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Tadasu, Kasahara, Osamu, Tomonaga, Hideo, Nunome, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
To determine the efficacy and safety of sitagliptin when used with some therapeutic drugs to treat elderly patients. Sitagliptin (50 mg/day) was added to the pre-existing therapy for type 2 diabetes. Changes in the glycated hemoglobin (HbA1c) level a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bcc628e0b5943ab45db309bfdc6bfc
https://europepmc.org/articles/PMC6224874/
https://europepmc.org/articles/PMC6224874/
Publikováno v:
Diabetes and Endocrinology. 1
HbA1c levels decreased with increasing Hb levels, independent of age, sex, BMI, FPG, and smoking and alcohol habits in Japanese men and women without diabetes or anemia. There was an interaction between sex and hemoglobin in the effects on HbA1c. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94c8bdffb7b97035bd9756a6df7a5982
https://doi.org/10.24983/scitemed.de.2017.00044
https://doi.org/10.24983/scitemed.de.2017.00044
Publikováno v:
Diabetology International. 2:154-158
We report the case of a female patient with type 1 diabetes mellitus who developed diabetes at 1 year and 7 months and is now over 60 years old (duration of type 1 diabetes, 59 years) and has experienced only mild diabetic complications. The patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c164cadd97ff3ee6bff070fddca89f7d
https://doi.org/10.1007/s13340-011-0034-y
https://doi.org/10.1007/s13340-011-0034-y